Abstract
Abstract
Background
In patients treated for head and neck cancer, imaging studies are usually obtained within 3–6 months after treatment for assessment of treatment response. After 6 months, most guidelines advocate clinical follow-up, with imaging reserved for patients with clinically suspect or equivocal findings. However, some guidelines do recommend systematic imaging surveillance, and many clinicians tend to include some type of imaging in their follow-up schemes.
Objectives
This systematic review focuses on the usefulness of routine (systematic) post-treatment imaging surveillance of head and neck cancer beyond the first 3–6-month baseline imaging study.
Methods
A systematic literature search was conducted using PubMed and Google Scholar. Additional studies were identified by reviewing reference lists. Only original studies and review papers were considered. Results obtained with systematic post-treatment surveillance imaging were compared to symptom-directed imaging and/or clinical finding-directed imaging.
Results
Five hundred twenty-one records were identified through the database search, and 44 additional records were identified through other sources. Forty-eight articles were selected for the final review.
Analysis of these records showed that almost half of cases of locoregional recurrences and/or metastases were only detected by imaging (40.9%), and the mean time of detection of recurrent or metastatic disease (11.5 months) was well beyond the period of the first post-treatment scan. Most authors reported superior results with PET-CT when compared to other imaging techniques.
Conclusion
Strong arguments were found in favor of systematic imaging surveillance in locoregional advanced head and neck cancer during at least one and preferably 2 years after treatment.
Critical relevance statement
Analysis of the selected records showed that almost half of cases of locoregional recurrences and/or metastases were only detected by imaging. This systematic review suggests that imaging may currently be underused in the post-treatment surveillance of patients with head and neck cancer.
Key points
• This systematic review focuses on the usefulness of long-term systematic imaging surveillance in patients treated for head and neck cancer.
• Analysis of 521 articles revealed that systematic imaging allowed the initial detection of locoregional recurrences and/or metastases in more than 40% of patients.
• Imaging may currently be underused in the post-treatment surveillance of patients with advanced head and neck cancer.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Stenson K, Brockstein B, Ross M (2023) Epidemiology and risk factors for head and neck cancer. In: UpToDate, Post TW (Ed), Wolters Kluwer (accessed on January 15, 2023)
2. Nissi L, Suilamo S, Kyto E, Vaittinen S, Irjala H, Minn H (2021) Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume. Clin Transl Radiat Oncol 27:139–146
3. Agarwal V, Branstetter B, Johnson J (2008) Indications for PET/CT in the head and neck. Otolaryngol Clin North Am 41:23–49
4. Pisani P, Airoldi M, Allais A et al (2020) Metastatic disease in head & neck oncology. Acta Otorhinolaryngol Ital 40:S1–S86
5. Leon X, Quer M, Diez S et al (1999) Second neoplasm in patients with head and neck cancer. Head Neck 21:204–210
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献